Doxazosin Tablet
Product Images NDC 68382-784

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Doxazosin (NDC 68382-784). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Doxazosin Tablets, Usp (92ead971 9de8 4240 B2c7 Fc2e9abac7dd 01)

Chemical structure of doxazosin, illustrating its molecular composition and arrangement including aromatic rings, nitrogen atoms, and functional groups as part of the compound structure.*

FDA Label Image

Doxazosin Tablets (92ead971 9de8 4240 B2c7 Fc2e9abac7dd 02)

A data table and bar chart presenting clinical study results comparing Doxazosin (4 mg and 8 mg) to placebo. The table shows symptom scores and maximum flow rate measurements, with mean baseline and mean change values from three studies examining titration to fixed doses and maximum dosage. The bar chart highlights the maximum flow rate change from baseline in Study 2, illustrating statistically significant improvement with Doxazosin versus placebo.*

FDA Label Image

Doxazosin Tablets, Usp (92ead971 9de8 4240 B2c7 Fc2e9abac7dd 03)

Two line graphs depicting clinical study results for Doxazosin compared to placebo over a 14-week treatment period. The left graph shows mean change in total symptom score from baseline, with Doxazosin patients demonstrating greater symptom reduction than placebo. The right graph illustrates mean increase in maximum urinary flow rate, where Doxazosin shows a higher improvement compared to placebo. Both graphs include error bars and sample sizes (N=50 for Doxazosin, N=47 for placebo).*

FDA Label Image

Container Label 1 mg (100s count)

Doxazosin Tablets USP 1 mg oral tablets packaging label from Zydus Pharmaceuticals USA Inc. The label indicates a 100-tablet count, prescription use only, and includes dosage information, storage instructions, and child-resistant packaging details. The label shows the product NDC 68382-783-01 and manufacturer details from India and distribution in the USA.*

FDA Label Image

Container Label 2 mg- 100s Count (92ead971 9de8 4240 B2c7 Fc2e9abac7dd 05)

Doxazosin Tablets USP 2 mg oral tablets packaging label from Zydus Pharmaceuticals USA Inc. The label states 100 tablets per bottle, Rx only, child-resistant packaging, and storage instructions at 20°C to 25°C. It lists Doxazosin Mesylate as the active ingredient and indicates the product is made in Germany and distributed by Zydus Pharmaceuticals (USA) Inc.*

FDA Label Image

Container Label 4 mg (100s count)

Label for Doxazosin Tablets, USP 4 mg oral tablets by Zydus Pharmaceuticals USA Inc. The package contains 100 tablets and is marked Rx only. The label includes dosage strength, manufacturer and distributor information, and storage instructions emphasizing a child-resistant package.*

FDA Label Image

Container Label (8 mg)

Doxazosin Tablets USP 8 mg oral tablets label. The package contains 100 tablets and is labeled for prescription use only. Manufacturer is Zydus Pharmaceuticals USA Inc. The label lists each tablet contains 8 mg of doxazosin, includes storage instructions, and states the package is child-resistant.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.